1d
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...
11d
MedPage Today on MSNTopical Therapies for PsoriasisOptimizing use of topical agents begins with defining "mild or moderate." Clinical trials in psoriasis employ objective ...
11d
MedPage Today on MSNInitiating Systemic Therapy for PsoriasisUntil about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...
Our immune system is constantly working to protect us from infections and injuries. One of its most powerful tools is ...
More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results